Kentucky Ranks Among Top States for E-Cigarette Use, Study Finds

Industry Insight by 2FIRSTS.ai
May.31.2024
Kentucky Ranks Among Top States for E-Cigarette Use, Study Finds
A recent study by Forbes Advisor shows Kentucky tops US in e-cigarette use among 18-24 year olds, with Tennessee leading growth.

According to a report from FOX 56 on May 30th, a recent study on Americans aged 18 to 24 (Z generation) from 2017 to 2022 showed that Kentucky's Z generation is one of the most frequent users of e-cigarettes nationwide.

 

Forbes Advisor analyzed "hundreds of data points" on e-cigarette use among Generation Z age group in all 50 states from the Centers for Disease Control and Prevention (CDC) over a six-year period (2016 to 2022). The study found that e-cigarette users in Kentucky increased by 4.9% in the past six years, which is higher than the average rate of 3.1%. Furthermore, Kentucky has the highest proportion of daily e-cigarette users in the United States, reaching 6%.

 

Despite having a lower number of adult e-cigarette users per day compared to Kentucky, Tennessee ranks first in a recent study due to the higher percentage growth of Generation Z individuals using e-cigarettes and other related products at 5.1%.

 

According to the data, seven of the ten states with the highest number of e-cigarette users are located in the South: Alabama, Arkansas, Kentucky, Louisiana, Oklahoma, Tennessee, and West Virginia. The survey also shows that the other states in the top ten for the highest number of e-cigarette users in Generation Z are Idaho, North Dakota, and Hawaii.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Indonesian vape retailers’ association tells members to halt sales to under-21 customers
Indonesian vape retailers’ association tells members to halt sales to under-21 customers
The Indonesian Vape Retailers Association (Arvindo) has instructed all member stores to stop selling electronic cigarettes to customers under 21. Arvindo said it issued an official circular requiring vape shops to display 21+ signage and to ask customers for valid identification.
Feb.26
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opens for Tasmania’s Public Health Amendment Bill 2026
Consultation opened on February 6, 2026 for the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026. The Bill intends to address illicit trade in tobacco, nicotine pouches and e-cigarettes, which has increased significantly across Tasmania in recent years. It proposes changes to the Public Health Act 1997 to further protect the health of Tasmanians by reducing the sale and supply of illicit tobacco, vaping and other products, and to strengthen existing tobacco control laws.
Feb.06 by 2FIRSTS.ai
Mexico’s Coahuila State Passes Vape Ban Covering Non-Nicotine Devices and Heated Tobacco Products
Mexico’s Coahuila State Passes Vape Ban Covering Non-Nicotine Devices and Heated Tobacco Products
The Congress of Coahuila in Mexico has approved a ban on the sale, use and promotion of vapes and similar devices, citing their harmful effects on health and the environment.
Mar.31 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp, an online retailer of alternative nicotine products, has confirmed it is exiting the UK vape category as it shifts focus to the oral nicotine market. The company said analysis of its sales data showed increasing adoption of nicotine pouches across its six international markets: the UK, the USA, Germany, Norway, Switzerland and Sweden.
Mar.04 by 2FIRSTS.ai